F-star CEO: Revamped Merck KGaA Pact Is First Step In New Corp Direction

 
• By Sten Stovall

F-star CEO tells Scrip reconfiguring biotech’s pact with Merck KGaA on oncology asset FS118 is UK group’s first big move towards a wholly owned portfolio strategy.

New_Direction
F-star is building a proprietary pipeline while retaining collaborations • Source: Shutterstock

More from Business

More from Scrip